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Introduction {#sec1}
============

Parvalbumin (PV)-positive interneurons, a major type of inhibitory neurons in the brain, are characterized by both their short action potential duration and their ability to fire at high frequencies ([@bib27], [@bib28]). PV interneurons have multiple dendrites receiving inputs from diverse afferent pathways ([@bib20]; [@bib24]), as well as numerous perisomatic boutons onto excitatory neurons ([@bib3]; [@bib10]), together resulting in an integrated feedforward and feedback inhibitory control of both local circuitry and distant neuronal networks ([@bib11]; [@bib15]; [@bib49]; [@bib58]; [@bib63]). Through their role in generating network oscillations ([@bib2]; [@bib9]; [@bib19]; [@bib63]) and their ability to undergo plastic changes upon learning ([@bib13], [@bib14]), PV interneurons are of crucial importance in memory processes, e.g., in spatial memory consolidation in the hippocampus ([@bib13]; [@bib43]; [@bib66]). Inhibiting hippocampal PV interneurons during consolidation was found to disrupt context fear memory in mice ([@bib43]; [@bib66]). Conversely, inhibition of hippocampal PV neurons during Morris water maze (MWM) training was shown to improve spatial memory ([@bib13]). It is also suggested that PV interneurons regulate the precise timing of action potential initiation in pyramidal neuron ensembles encoding hippocampal memories ([@bib1]; [@bib53]). In addition, various studies have proposed that an optimal balance between excitation and inhibition in hippocampal circuits is crucial for successful memory recall ([@bib37]; [@bib44]; [@bib54]; [@bib59]; [@bib68]). Given the important role of PV neurons in memory formation and recall in hippocampal circuits, it is not surprising that PV cell dysfunction has been linked to several brain diseases that involve memory deficits ([@bib23]; [@bib42]; [@bib52]).

In Alzheimer disease (AD), a neurodegenerative disease that accounts for the most common cause of dementia ([@bib33]), PV interneuron dysfunction has been recently highlighted ([@bib23]; [@bib48]; [@bib64]). Studies aimed at restoring PV neuron function were successful at reinstating network oscillations and network synchrony and improved cognitive functions in several mouse models of AD ([@bib16]; [@bib23]; [@bib29]; [@bib36]). PV interneuron impairment and reduced inhibitory transmission are proposed to underlie changes in the excitability of principal networks in AD ([@bib7]; [@bib46]) and may develop over time, including stages of both hyper- ([@bib23]; [@bib26]; [@bib32]; [@bib46]) and hypoexcitability ([@bib36]; [@bib48]; [@bib64]). We previously demonstrated that hippocampal PV interneurons are initially hyperexcitable in a mouse model of AD and that preventing their hyperexcitability early in the disease process is sufficient to rescue spatial memory deficits, avert the loss of inhibitory synaptic transmission, and prevent pyramidal neuron hyperexcitability at later disease stages ([@bib23]).

Several studies showed that neuronal hyperexcitability can be caused by amyloid beta (Ab), the peptide responsible for pathological protein aggregation in AD, suggesting that it is a consequence of the disease process rather than a causal factor in the disease. For instance, reducing Ab levels restored neuronal activity and circuit function as well as memory performance, whereas the addition of Ab to brain slices *in vitro* or to brains *in vivo* caused significant neuronal hyperactivation ([@bib7]; [@bib23]; [@bib31]; [@bib38]; [@bib69]). What has not been tested to date is whether neuronal hyperexcitability also increases the risk to develop AD and whether alterations in the excitability of the brain\'s circuits along with an age-dependent increase in Ab levels could predispose for developing AD. In this study, we tested whether PV hyperexcitability alone could lead to memory deficits and hippocampal circuit dysfunction and importantly, whether such alterations in hippocampal microcircuits predispose for Ab-induced toxicity. Our data show that prolonged chemogenetic activation of PV interneurons in the CA1 of the hippocampus resulted in PV neuron hyperexcitability, memory impairments, and alterations in synaptic transmission similar to what is observed in AD mouse models. On the long term, however, in the absence of Ab, pyramidal cells also became hyperexcitable and synaptic transmission and spatial memory were restored. Importantly, this long-term hyperstate of both PV and pyramidal neurons showed extreme sensitivity to a single low-dose infusion of Ab oligomers, which only under these conditions was sufficient to impair hippocampal spatial memory and network function. Taken together, our data suggest that early hyperexcitable PV neurons can prime neuronal network vulnerability and generate a predisposed state for eliciting AD-like neuronal and behavioral phenotypes.

Results {#sec2}
=======

Increased Hippocampal PV Neuron Excitability Induces Spatial Memory Deficits {#sec2.1}
----------------------------------------------------------------------------

To selectively increase hippocampal PV neuron activity *in vivo* in PV-Cre mice, the activating hM3dq receptor was bilaterally expressed in the CA1 area of the hippocampus using Cre-dependent AAV hSyn-DIO-hM3Dq-mCherry ([Figures 1](#fig1){ref-type="fig"}A and 1B). On average, 86% of the PV interneurons in the CA1 expressed hM3Dq-mCherry, and 88% mCherry-positive cells expressed PV ([Figure 1](#fig1){ref-type="fig"}C). In hippocampal slice preparations of these animals, bath application of clozapine-N-oxide (CNO) at 10 μM resulted in a significant depolarization of mCherry-positive cells and an increase in the number of action potentials at rheobase ([Figures 1](#fig1){ref-type="fig"}D--1G), confirming the functionality of the hM3Dq receptor in increasing PV neuron excitability. To validate the effect of CNO *in vivo*, mice expressing hM3Dq-mCherry in hippocampal PV neurons were injected intraperitoneally (i.p.) with either CNO (2mg/kg) or saline in their home cage and sacrificed 90 min later to quantify expression of cFos, a marker for cellular activation ([@bib18]), in the targeted cells. Mice that received CNO injections showed a significant increase in cFos-positive PV neurons compared with saline-injected mice ([Figures 1](#fig1){ref-type="fig"}H and 1I).Figure 1Chemogenetic Activation of PV Neurons during MWM Training Induces a Memory Deficit in the Probe Trial(A) Representative overview (top) and zoom (bottom) images of PV immunostaining (green) and mCherry expression (red) in the CA1 region of the hippocampus of PV-Cre mice injected with AAV hSyn-DIO-hM3Dq-mCherry (blue: DAPI).(B) Overlay of mCherry labeling and PV staining indicating that mCherry expression is restricted to PV neurons in the CA1 region of the hippocampus. Scale bars: 200 μm (top); 70 μm (bottom).(C) Bar graphs showing the percentage of PV-positive cells expressing mCherry and of the fraction of mCherry-positive cells expressing PV (*n* = 4 mice).(D) Animals were injected with hM3Dq virus and sacrificed 4 weeks later for either slice electrophysiology or immunohistochemistry. Brains were acquired for cFos analysis 90 min following injection of saline or CNO (1mg/kg of body weight, i.p.).(E) Representative voltage trace of a 10 μM CNO-induced depolarization in an hM3Dq-positive neuron.(F) Representative voltage responses to 1 s hyperpolarizing or depolarizing current steps from an hM3Dq-expressing PV neuron before and after CNO application indicating an increase in AP firing at rheobase.(G) Quantification of the increase in AP firing at rheobase before and after CNO (Student\'s t test: *n* = 4 cells from 2 mice, p = 0.02).(H) Example of co-localization of PV+ (magenta), mCherry+ (red), and cFos+ (green) cells in the CA1 region of CNO-injected compared with saline-injected mice. White arrowheads indicate mCherry+/PV+/cFos + cells. Scale bar: 70 μm.(I) Quantification of percentage cFos+/PV + neurons in the CA1 region of the hippocampus confirms that CNO, but not saline injections, induced cFos immunoreactivity in hM3Dq-expressing PV neurons.(J) PV-Cre mice were injected with hM3Dq virus or mCherry-control virus and tested in a Morris water maze (MWM) test 4 weeks later. CNO (2 mg/kg) was i.p. injected 30 min prior to each training session.(K) Spatial learning was assessed measuring the latency to find the hidden platform on four consecutive training days (T1--4). Both PV-Cre mice that expressed hM3Dq and received CNO, as well as mCherry-expressing mice that received CNO injections showed significant learning during training sessions (*training* two-way repeated measures ANOVA: *n* = 10 mice per group, *F*~*3,54*~ = 60.62, p \< 0.0001).(L) During the 1-min probe trial, CNO-treated PV-Cre mice expressing hM3Dq spent significantly less time in the target quadrant (TQ) compared with CNO-treated PV-Cre mice expressing mCherry (two-way ANOVA: n = 10 mice per group, F~3,68~ = 3.16, p = 0.03; post-hoc LSD test: ∗p = 0.012). Compared with chance level (dashed line), CNO-treated PV-Cre mice expressing mCherry spent significantly more time in the target quadrant, whereas CNO-treated PV-Cre expressing hM3Dq did not (Student\'s t test: p \< 0.01). TQ: target quadrant, BL: bottom left quadrant, TR: top right quadrant, and BR: bottom right quadrant. Values are mean ± SEM.

Next, we confirmed that increasing PV neuron excitability during MWM training impairs spatial memory performance as reported previously ([@bib13]). To that end, PV-Cre mice were injected with either hSyn-DIO-hM3Dq-mCherry- or the control hSyn-DIO-mCherry-expressing virus in the hippocampal CA1 region. Thirty minutes prior to each training session, mice received CNO (2 mg/kg) ([Figure 1](#fig1){ref-type="fig"}J). There was no significant difference between groups in the latency to find the platform during the four training days ([Figure 1](#fig1){ref-type="fig"}K); however during the probe test, hM3Dq-expressing mice that had received CNO spent significantly less time in the target quadrant compared with control mCherry-expressing mice and relative to chance level ([Figure 1](#fig1){ref-type="fig"}L). These findings demonstrate that increasing PV interneuron activity during learning impairs hippocampal spatial memory.

Prolonged Activation of Hippocampal PV Neurons Induces Spatial Memory Deficits, PV Hyperexcitability, and Network Imbalance {#sec2.2}
---------------------------------------------------------------------------------------------------------------------------

Next, we aimed to test whether prolonged chemogenetic activation of PV neurons leads to hippocampal circuit alterations and memory deficits in the absence of acute effects of CNO. To that end, mice expressing hM3Dq virus in hippocampal PV interneurons received daily injections of CNO (1 mg/kg) or saline for a period of 3 weeks and were subjected to an MWM test 48 h after the last injection ([Figure 2](#fig2){ref-type="fig"}A). CNO- and saline-injected mice showed a similar decrease in the latency to find the platform with training ([Figure 2](#fig2){ref-type="fig"}B). However, in the probe trial, CNO-injected mice displayed a clear spatial memory deficit and explored the target quadrant at chance level, significantly less than saline-injected control mice ([Figure 2](#fig2){ref-type="fig"}C).Figure 2Prolonged Activation of Hippocampal PV Interneurons Causes Spatial Memory Deficits, PV Neuron Hyperexcitability, and Network Imbalance on the Short Term(A) PV-Cre mice were injected with hM3Dq virus at 8--10 weeks of age. After 4 weeks, CNO (1 mg/kg) or saline were i.p. injected daily for a period of 3 weeks. An MWM test was performed 48 h after discontinuation of CNO injections. Electrophysiological recordings were performed following the MWM test.(B) Spatial learning was assessed measuring the latency to find the hidden platform on four consecutive training days (T1--4). Both PV-Cre mice that expressed hM3Dq and had received CNO injections or saline injections showed significant learning during training (*training* two-way repeated measures ANOVA: *n* = 11/12 mice per group, *F*~*3,60*~ = 40.50, p \< 0.0001).(C) During the 1-min probe trial, CNO-injected PV-Cre mice expressing hM3Dq spent significantly less time in the target quadrant (TQ) compared with PV-Cre mice receiving control saline injections (two-way ANOVA: n = 11/12 mice per group, F~3,84~ = 4.12, p = 0.009; post-hoc LSD test: ∗∗p = 0.002). Compared with chance level (dashed line), saline-injected PV-Cre mice spent significantly more time in the target quadrant, whereas CNO-injected PV-Cre mice did not (Student\'s t test: p \< 0.01).(D) PV interneuron resting membrane potential was not different between CNO-injected or saline-injected PV-Cre mice expressing hM3Dq (Student\'s t test: *n* = 18/24 cells from 5 mice per group, p = 0.514).(E) PV interneuron input resistance was significantly increased in CNO-injected compared with saline-injected PV-Cre mice expressing hM3Dq (Student\'s t test: *n* = 18/24 cells from 5 mice per group, ∗p = 0.018).(F) Voltage responses to 1 s hyperpolarizing or depolarizing current steps from a PV interneuron in saline-injected PV-Cre (gray) and CNO-injected PV-Cre (blue) mice.(G) Average action potential (AP) frequency in response to 0--250 pA depolarizing current steps illustrating a significant increase in PV interneuron excitability in CNO-injected PV-Cre mice compared with saline-injected PV-Cre mice (*group x current* two-way repeated measures ANOVA: *n* = 18/24 cells from 5 mice per group, *F*~*1,30*~ = 7.13, p = 0.012).(H and I) Pyramidal neuron resting membrane potential (H) and input resistance (I) were unaltered in CNO-injected PV-Cre mice compared with saline-injected PV-Cre controls (Student\'s t test: *n* = 29/25 cells from 5 mice per group, p = 0.437 and p = 0.534).(J) Voltage responses to 1 s hyperpolarizing or depolarizing current steps from a pyramidal neuron in a saline-injected PV-Cre mouse (gray) or a CNO-injected PV-Cre mouse (blue).(K) AP frequency in response to 0--250 pA depolarizing current steps illustrating no significant change in pyramidal neuron excitability in CNO-injected PV-Cre mice compared with saline-injected PV-Cre controls (*group x current* two-way repeated measures ANOVA: *n* = 29/25 cells from 5 mice per group, *F*~*1,38*~ = 0.02, p = 0. 882).(L) Example traces of spontaneous inhibitory postsynaptic currents (sIPSC) recorded from hippocampal pyramidal neurons in saline-injected PV-Cre mouse (gray) or a CNO-injected PV-Cre mouse (blue).(M) Decreased sIPSC frequency in CNO-injected PV-Cre mice compared with saline-injected controls (Mann-Whitney test: *n* = 14/12 cells from 4 mice per group, ∗∗∗p = 0.000).(N) No alterations were observed in the amplitudes of sIPSCs (Mann-Whitney test: *n* = 14/12 cells from 4 mice per group, p = 0.526).(O) Example traces of spontaneous excitatory postsynaptic currents (sEPSC) recorded from hippocampal pyramidal neurons in saline-injected PV-Cre mouse (gray) or a CNO-injected PV-Cre mouse (blue).(P and Q) No significant alterations were observed in the frequency (P) or in the amplitude (Q) of sEPSCs in CNO-injected PV-Cre mice compared with saline-injected PV-Cre controls (Mann-Whitney test: *n* = 14/12 cells from 4 mice per group, p = 0.595 and p = 0.347). Values are mean ± SEM.

We then asked whether PV neuron excitability had changed due to prolonged chemogenetic activation. Intrinsic properties of PV interneurons were assessed using whole-cell patch clamp recording from mCherry-expressing cells. An increase in the excitability of PV interneurons in the CNO-injected group compared with the saline group was confirmed ([Figures 2](#fig2){ref-type="fig"}D--2G; [Table S1](#mmc1){ref-type="supplementary-material"}). Specifically, PV interneurons of CNO-injected mice had no alterations in resting membrane potential ([Figure 2](#fig2){ref-type="fig"}D) but did show a significantly larger input resistance compared with saline-injected mice ([Figure 2](#fig2){ref-type="fig"}E). Importantly, PV neurons from CNO-injected mice also presented a significant decrease in rheobase, a significant increase in action potential firing frequency with increasing current injections, and a significantly smaller action potential half-width ([Figures 2](#fig2){ref-type="fig"}F and 2G; [Table S1](#mmc1){ref-type="supplementary-material"}), indicating hyperexcitability. Interestingly, no changes in the excitability of pyramidal neurons was observed at this time point ([Figures 2](#fig2){ref-type="fig"}H--2K, [Table S1](#mmc1){ref-type="supplementary-material"}).

To explore how hyperexcitable PV neurons affect synaptic transmission in the hippocampus, we recorded spontaneous inhibitory postsynaptic currents (sIPSCs) and excitatory postsynaptic currents (sEPSCs) from hippocampal pyramidal neurons after discontinuation of CNO treatment. Surprisingly, a significant decrease was observed in the frequency of sIPSCs received by CA1 pyramidal neurons in CNO-injected mice compared with saline controls ([Figures 2](#fig2){ref-type="fig"}L and 2M), whereas sIPSC amplitudes were not affected ([Figure 2](#fig2){ref-type="fig"}N), suggesting a decrease in the number of inhibitory synaptic inputs. No differences were found in the frequency or amplitudes of sEPSCs recorded at this time point ([Figures 2](#fig2){ref-type="fig"}O--2Q). Taken together, these data show that prolonged activation of hippocampal PV neurons induces spatial memory deficits, accompanied with hyperexcitability of PV neurons and a decrease in inhibitory input in the hippocampus.

Spatial Memory Deficits after Prolonged Activation of Hippocampal PV Neurons Are Transient {#sec2.3}
------------------------------------------------------------------------------------------

Next, we examined whether memory deficits caused by prolonged PV neuron activation are long-lasting. Accordingly, we tested mice 8 weeks after the last CNO or saline injections ([Figure 3](#fig3){ref-type="fig"}A). Both CNO- and saline-injected mice showed no learning deficits during the MWM training ([Figure 3](#fig3){ref-type="fig"}B), and in the probe test both groups spent significantly more time in the target quadrant compared with chance level ([Figure 3](#fig3){ref-type="fig"}C), indicating intact spatial memory. Interestingly, CNO-treated mice showed a significantly higher preference for the target quadrant than saline-injected mice, suggesting that, in contrast to an earlier impairment in spatial memory shortly after CNO treatment, prolonged activation of PV neurons results in an improvement of spatial memory on the long term.Figure 3Prolonged Chemogenetic Activation of Hippocampal PV Interneurons Induces a Hyperexcitable Hippocampal Network but Does Not Impair Spatial Memory on the Long Term(A) PV-Cre mice were injected with hM3Dq virus at 8--10 weeks of age. After 4 weeks, CNO (1 mg/kg) or saline were i.p. injected daily for a period of 3 weeks. Behavioral testing and electrophysiological recordings were performed 8 weeks after discontinuation of CNO injections.(B) Spatial learning was assessed measuring the latency to find the hidden platform on four consecutive training days (T1--4). PV-Cre mice that both expressed hM3Dq and had received CNO injections or saline injections showed significant learning during training (*training* two-way repeated measures ANOVA: *n* = 10 mice per group, F~2,27~ = 43.65, p \< 0.001).(C) During the one-minute probe trial, CNO-injected PV-Cre mice expressing hM3Dq spent significantly more time in the target quadrant (TQ) compared with PV-Cre mice receiving control saline injections (two-way ANOVA: n = 10 mice per group, F~3,72~ = 4.42, p = 0.006, post-hoc LSD test: ∗∗p = 0.009). Compared with chance level (dashed line), both saline-injected PV-Cre mice and CNO-injected PV-Cre mice spent significantly more time in the target quadrant (Student\'s t test: p \< 0.01 for saline and p \< 0.001 for CNO).(D) PV interneuron resting membrane potential was not different between CNO-injected or saline-injected PV-Cre mice expressing hM3Dq (Student\'s t test: *n* = 14/20 cells from 4 mice per group, p = 0.776).(E) PV interneuron input resistance was significantly increased in CNO-injected compared with saline-injected PV-Cre mice expressing hM3Dq (Student\'s t test: *n* = 14/20 cells from 4 mice per group, ∗∗∗p = 0.000).(F) Voltage responses to 1 s hyperpolarizing or depolarizing current steps from a PV interneuron in saline-injected PV-Cre (gray) and CNO-injected PV-Cre (blue) mice.(G) Average action potential (AP) frequency in response to 0--250 pA depolarizing current steps illustrating a significant increase in PV interneuron excitability in CNO-injected PV-Cre mice compared with saline-injected PV-Cre mice (*group x current* two-way repeated measures ANOVA: *n* = 14/20 cells from 4 mice per group, *F*~*1,42*~ = 4.32, ∗p = 0.044).(H) Pyramidal neuron resting membrane potential was unaltered in CNO-injected PV-Cre mice compared with saline-injected PV-Cre controls (Student\'s t test: *n* = 25/24 cells from 5 mice per group, p = 0.123).(I) Pyramidal neuron input resistance was significantly increased in CNO-injected compared with saline-injected PV-Cre mice expressing hM3Dq (Student\'s t test: *n* = 25/24 cells from 5 mice per group, ∗p = 0.031).(J) Voltage responses to 1 s hyperpolarizing or depolarizing current steps from a pyramidal neuron in a saline-injected PV-Cre mouse (gray) or a CNO-injected PV-Cre mouse (blue).(K) AP frequency in response to 0--250 pA depolarizing current steps illustrating a significant increase in pyramidal neuron excitability in CNO-injected PV-Cre mice compared with saline-injected PV-Cre controls (*group x current* two-way repeated measures ANOVA: *n* = 25/24 cells from 5 mice per group, *F*~*1,21*~ = 7.74, ∗p = 0.011).(L) Example traces of spontaneous inhibitory postsynaptic currents (sIPSC) recorded from hippocampal pyramidal neurons in saline-injected PV-Cre mouse (gray) or a CNO-injected PV-Cre mouse (blue).(M and N) No significant alterations were observed in the frequency (M) or in the amplitude (N) of sIPSCs in CNO-injected PV-Cre mice compared with saline-injected PV-Cre controls (Mann-Whitney test: *n* = 11/14 cells from 4 mice per group, p = 0.727 and p = 0.267).(O) Example traces of spontaneous excitatory postsynaptic currents (sEPSC) recorded from hippocampal pyramidal neurons in saline-injected PV-Cre mouse (gray) or a CNO-injected PV-Cre mouse (blue).(P and Q) No significant alterations were observed in the frequency (P) or in the amplitude (Q) of sEPSCs in CNO-injected PV-Cre mice compared with saline-injected PV-Cre controls (Mann-Whitney test: *n* = 11/14 cells from 4 mice per group, p = 0.195 and p = 0.193). Values are mean ± SEM.

We then investigated whether the observed changes in memory performance over time was paralleled by a rescue of PV neuron excitability and hippocampal synaptic transmission. Surprisingly, PV interneurons were still hyperexcitable in CNO-injected mice 8 weeks after the treatment ([Figures 3](#fig3){ref-type="fig"}D--3G, [Table S2](#mmc1){ref-type="supplementary-material"}). There was no difference in the resting membrane potential of PV neurons ([Figure 3](#fig3){ref-type="fig"}D), and they showed a significantly larger input resistance compared with saline-injected mice ([Figure 3](#fig3){ref-type="fig"}E). Notably, PV neurons from CNO-injected mice presented a significant decrease in rheobase ([Table S2](#mmc1){ref-type="supplementary-material"}) and a significant increase in action potential firing frequency with increasing current injections ([Figures 3](#fig3){ref-type="fig"}F and 3G), demonstrating that PV neurons were still hyperexcitable at this time point. Interestingly, we also observed an increase in pyramidal neuron excitability in CNO-injected mice ([Figures 3](#fig3){ref-type="fig"}H--3K, [Table S2](#mmc1){ref-type="supplementary-material"}). Resting membrane potential of pyramidal neurons was not changed ([Figure 3](#fig3){ref-type="fig"}H), but there was a significant increase in their input resistance in CNO-injected mice compared with saline-injected control mice ([Figure 3](#fig3){ref-type="fig"}I). Pyramidal neurons from CNO-injected mice also showed a significant decrease in rheobase, a significant increase in action potential firing frequency with increasing current injections, and a decrease in action potential amplitudes ([Figures 3](#fig3){ref-type="fig"}J and 3K; [Table S2](#mmc1){ref-type="supplementary-material"}). Synaptic transmission onto pyramidal neurons was unaltered at this time point ([Figures 3](#fig3){ref-type="fig"}L--3Q), as no significant differences in frequency or amplitudes of either sIPSCs ([Figures 3](#fig3){ref-type="fig"}L--3N) or sEPSCs ([Figures 3](#fig3){ref-type="fig"}O--3Q) were observed. Together, these data suggest that an initial hyperexcitability of PV neurons induces, on the long-term, a new, functional hyperstate marked by an overall increase in excitability of both PV neurons and pyramidal cells, restoration of synaptic transmission, and an improvement of spatial memory.

Increasing Hippocampal PV Neuron Excitability Creates a Vulnerable Network State that Is Sensitive to Amyloid Beta {#sec2.4}
------------------------------------------------------------------------------------------------------------------

Our data so far demonstrated that memory deficits due to PV neuron hyperexcitability alone are not permanent, likely because hippocampal pyramidal neurons show a compensatory increase in excitability in an attempt to restore E/I balance. We then tested whether and how Ab oligomers would affect this state of the network. To answer this question, 0.3 μL of a 0.5 nM solution of Ab oligomers (0.15 femtomole Ab), were infused bilaterally in the CA1 region of the hippocampus of CNO-injected mice 1--2 weeks before the MWM test. In control mice that had previously received saline injections instead of CNO, this low concentration of Ab had no effect on spatial memory, PV and pyramidal neuron intrinsic properties, or synaptic transmission in the hippocampus ([Figure S1](#mmc1){ref-type="supplementary-material"}, [Table S3](#mmc1){ref-type="supplementary-material"}). In contrast, this single low dose of Ab in the hippocampus of CNO-injected mice was sufficient to cause a significant spatial memory deficit ([Figures 4](#fig4){ref-type="fig"}A--4C). Although there was no apparent difference during training ([Figure 4](#fig4){ref-type="fig"}B), Ab-infused mice showed impaired memory compared with PBS-infused control mice in the probe trial ([Figure 4](#fig4){ref-type="fig"}C).Figure 4Increasing Hippocampal PV Neuron Excitability Creates a Vulnerable Network State that Is Sensitive to Ab(A) PV-Cre mice were injected with hM3Dq virus at 8--10 weeks of age. After 4 weeks, CNO (1 mg/kg) or saline were i.p. injected daily for a period of 3 weeks. Bilateral infusion of 0.15 fmole of Ab or PBS control in the CA1 region of the hippocampus of PV-Cre mice was completed 6.5 weeks after discontinuation of CNO injections. An MWM test was performed 1.5 week after Ab infusions. Electrophysiological recordings were performed following the MWM test.(B) Spatial learning was assessed measuring the latency to find the hidden platform on four consecutive training days (T1--4). Both Ab-infused and PBS-infused PV-Cre mice that expressed hM3Dq and had received CNO injections showed significant learning during training (*training* two-way repeated measures ANOVA: *n* = 17/13 mice per group, F~3,72~ = 47.65, p \< 0.000).(C) During the one-minute probe trial, Ab-infused PV-Cre mice spent significantly less time in the target quadrant (TQ) compared with PBS-infused PV-Cre mice (two-way ANOVA: n = 17/13 mice per group, F~3,112~ = 48.98, p = 0.000, post-hoc LSD test: ∗∗∗p = 0.000). Compared with chance level (dashed line), PBS-infused PV-Cre mice spent significantly more time in the target quadrant, whereas Ab-infused PV-Cre did not (Student\'s t test: p \< 0.001 for CNO and p = 0.059 for CNO + Ab).(D) PV interneuron resting membrane potential was significantly increased in Ab-infused PV-Cre mice compared with PBS-infused PV-Cre mice (Student\'s t test: *n* = 16/15 cells from 4 mice per group, ∗∗p = 0.004).(E) There was no difference in PV interneuron input resistance between Ab-infused and PBS-infused PV-Cre mice that expressed hM3Dq and had received CNO injections (Student\'s t test: *n* = 16/15 cells from 4 mice per group, p = 0.740).(F) Voltage responses to 1 s hyperpolarizing or depolarizing current steps from a PV interneuron in PBS-infused (blue) and Ab-infused (red) PV-Cre mice that expressed hM3Dq and had received CNO injections.(G) Average action potential (AP) frequency in response to 0--250 pA depolarizing current steps illustrating a significant decrease in PV interneuron firing frequency in Ab-infused compared with PBS-infused PV-Cre mice expressing hM3Dq and had received CNO injections (*group x current* two-way repeated measures ANOVA: *n* = 16/15 cells from 4 mice per group, *F*~*1,30*~ = 5.76, ∗p = 0.023).(H) Pyramidal neuron resting membrane potential was unaltered in Ab-infused compared with PBS-infused PV-Cre mice expressing hM3Dq and had received CNO injections (Student\'s t test: *n* = 14/15 cells from 4 mice per group, p = 0.300).(I) Pyramidal neuron input resistance was not changed in Ab-infused compared with PBS-infused PV-Cre mice that expressed hM3Dq and had received CNO injections (Student\'s t test: *n* = 14/15 cells from 4 mice per group, p = 0.070).(J) Voltage responses to 1 s hyperpolarizing or depolarizing current steps from a pyramidal neuron in PBS-infused (blue) and Ab-infused (red) PV-Cre mice that expressed hM3Dq and had received CNO injections.(K) AP frequency in response to 0--250 pA depolarizing current steps illustrating a significant increase in pyramidal neuron excitability in Ab-infused compared with PBS-infused PV-Cre mice that expressed hM3Dq and had received CNO injections starting at 150 pA (*group x current* two-way repeated measures ANOVA: *n* = 14/15 cells from 4 mice per group, *F*~*1,30*~ = 1.25, ∗p = 0.02).(L) Example traces of spontaneous inhibitory postsynaptic currents (sIPSC) recorded from hippocampal pyramidal neurons in PBS-infused (blue) or Ab-infused (red) PV-Cre mice that expressed hM3Dq and had received CNO injections.(M and N) No significant alterations were observed in the frequency (M) or in the amplitude (N) of sIPSCs in Ab-infused compared with PBS-infused PV-Cre mice that expressed hM3Dq and had received CNO injections (Mann-Whitney test: *n* = 14/16 cells from 5 mice per group, p = 0.983 and p = 0.822).(O) Example traces of spontaneous excitatory postsynaptic currents (sEPSC) recorded from hippocampal pyramidal neurons in PBS-infused (blue) or Ab-infused (red) PV-Cre mice that expressed hM3Dq and had received CNO injections.(P) Decreased sEPSC frequency in Ab-infused compared with PBS-infused PV-Cre mice that expressed hM3Dq and had received CNO injections (Mann-Whitney test: *n* = 18/13 cells from 5 mice per group, ∗∗∗p = 0.000).(Q) No alterations were observed in the amplitudes of sEPSCs (Mann-Whitney test: *n* = 18/13 cells from 5 mice per group, p = 0.370). Values are mean ± SEM.

We then investigated the effects of Ab infusion in CNO-treated mice on neuronal intrinsic properties and synaptic transmission. The resting membrane potential of PV neurons in mice that received Ab was significantly higher than in the PBS controls ([Figure 4](#fig4){ref-type="fig"}D, [Table S4](#mmc1){ref-type="supplementary-material"}). Input resistance was not altered, yet PV neurons from mice that received Ab infusions fired less action potentials with increasing current injections compared with PBS controls ([Figures 4](#fig4){ref-type="fig"}E--4G). Pyramidal neurons on the other hand showed a tendency toward increased excitability after Ab infusion ([Table S4](#mmc1){ref-type="supplementary-material"}). Resting membrane potential and input resistance of pyramidal neurons were not altered ([Figures 4](#fig4){ref-type="fig"}H and 4I); however, pyramidal neurons in Ab-infused mice showed a significant increase in action potential firing frequency with increasing current injections ([Figures 4](#fig4){ref-type="fig"}J and 4K) and a significantly smaller action potential half-width ([Table S4](#mmc1){ref-type="supplementary-material"}) compared with PBS controls. Finally, synaptic transmission onto pyramidal neurons after Ab infusion was measured. There were no differences in frequency or amplitude of recorded sIPSCs ([Figures 4](#fig4){ref-type="fig"}L--4N), but a significant decrease in sEPSCs frequency ([Figures 4](#fig4){ref-type="fig"}O and 4P), not amplitude ([Figure 4](#fig4){ref-type="fig"}Q), was observed. Together, these data suggest that prolonged activation of hippocampal PV neurons induced a hippocampal circuit state that is sensitive to disruption by Ab oligomers. In this state, Ab impairs PV neuron function, increases pyramidal neuron excitability, and disrupts synaptic transmission, resulting in a spatial memory deficit.

Discussion {#sec3}
==========

PV neurons are inhibitory neurons that support synchronous firing of excitatory neurons, generate gamma oscillations, and control basic microcircuit functions as well as complex brain network computations ([@bib2]; [@bib27]). Yet, due to their high energy-demanding fast-spiking properties ([@bib30]), PV neurons are also vulnerable to various stressors, and their dysfunction has been associated with several brain diseases ([@bib35]), including AD ([@bib47]). We previously demonstrated, in an amyloidosis mouse model of AD, that PV neuron dysfunction may be initiated by PV neuron hyperexcitability, and that early memory deficits in these mice are rescued when PV neuron excitability is restored early ([@bib23]). In the present study we show that PV neuron hyperexcitability alone can cause memory impairments and that inducing PV hyperexcitability is sufficient to create a vulnerable hippocampal circuit onto which disease-related stressors can act. Specifically, prolonged chemogenetic activation of hippocampal PV neurons can effectively induce PV neuron hyperexcitability, a phenotype that is still consistent at least 8 weeks after the end of the CNO treatment. Moreover, this sustained PV neuron hyperexcitability state comes with an increase in the excitability of pyramidal neurons, resulting in a hyperstate of the hippocampal circuitry that is vulnerable to Ab-induced impairment of both neuronal network function and spatial memory.

A Pharmacogenetic Model of PV Neuron Hyperexcitability {#sec3.1}
------------------------------------------------------

In APP/PS1 mice, initial hyperexcitability of PV neurons at 3--4 months of age is followed by a decrease in PV neuron function and inhibitory transmission at 5--6 months of age ([@bib23]; [@bib32]). A similar decrease in PV neuron function has been observed in several other mouse models of AD ([@bib41]; [@bib48]; [@bib64]). In such genetic models, however, increased Ab levels and neuronal dysfunction develop in parallel, and their separate contributions to disease pathogenesis or mutual interdependencies cannot easily be disentangled. We therefore established a model in which hyperexcitability of PV neurons is induced in the absence of Ab. This allowed us first to answer the question whether an early impairment of inhibitory transmission would affect spatial memory on the long term and second, whether the subsequently induced state of the hippocampal network would be prone to disruptive effects of Ab. Following three weeks of PV neuron activation, mice showed clear spatial memory deficits in the MWM test. Electrophysiological recordings confirmed that PV neurons were hyperexcitable at this time point, whereas pyramidal neuron intrinsic properties were not affected. Surprisingly, inhibitory synaptic inputs onto pyramidal neurons were reduced, as indicated by a significant decrease in sIPSCs frequencies. This may suggest a compensatory mechanism that prevents aberrant overinhibition of pyramidal neurons by hyperexcitable PV neurons. Interestingly, in APP/PS1 mice, PV neuron hyperexcitability was accompanied with an increase in sIPSCs frequency ([@bib23]), highlighting a different effect of early, genetically driven exposure to Ab in modulating synaptic compensatory mechanisms. Clearly, the interaction between PV cell hyperexcitability and a normal, age-dependent increase in Ab levels needs further investigation.

Dynamic Adaptations in Hippocampal Network Properties after Inducing PV Hyperexcitability {#sec3.2}
-----------------------------------------------------------------------------------------

Interestingly, PV neuron hyperexcitability alone did not result in memory impairment, but memory enhancement 8 weeks after discontinuation of the CNO treatment. When we investigated the underlying cell physiological changes, PV neurons were still hyperexcitable, and not hypoactive as observed in AD mouse models, demonstrating that PV neuron hyperexcitability alone cannot explain spatial memory deficits in AD mice. Interestingly, we found that pyramidal neuron excitability was also increased, which is likely a compensatory activity to restore the balance of the inhibitory and excitatory tone in the hippocampus. This is further confirmed by the fact that we found no differences in excitatory or inhibitory synaptic transmission onto pyramidal neurons at this point in time. This new hyperstate after 8 weeks, showing an overall increase in excitability of both inhibitory and excitatory neurons, may thus have developed to maintain E/I balance. It may also explain why spatial memory is enhanced, as it has been shown previously that increasing the excitability neurons promotes their allocation to memory engrams ([@bib21]; [@bib34]; [@bib37]; [@bib50]). Correlating levels of neuronal activation during recall to actual memory performance would help to elucidate this further. Behavioral recovery from a PV neuron hyperexcitability-induced memory impairment is in itself an interesting observation, and further investigation into the underlying molecular, cellular, and network mechanisms could reveal brain resilience mechanisms that are relevant for the etiology of AD. *In vivo* recordings of oscillatory network activity throughout such an intervention might additionally help provide an important link between the cellular changes reported in this study and the behavioral output.

PV Neuron Hyperexcitability Creates a Vulnerable Network State that Is Sensitive to Amyloid Beta {#sec3.3}
------------------------------------------------------------------------------------------------

We next hypothesized that, although the homeostatic adaptations in response to PV cell hyperexcitability may be beneficial under healthy conditions in order to compensate for neuron-specific alterations, they may increase sensitivity to disease-associated cellular stressors. In AD, this stressor is likely the gradual increase in soluble Ab levels. Indeed, our data show that a low concentration of Ab *in vivo* is able to significantly impair memory performance in mice that had received CNO injections to increase PV neuron excitability, while having no effect in saline-injected mice. On a cellular level, Ab affected the resting membrane potential of PV neurons in CNO-injected and, not in saline-injected, mice, an aberrant phenotype that is also observed in various mouse models of AD ([@bib23]; [@bib64]). Ab also reduced the firing frequency of previously activated PV neurons, a characteristic of crucial importance for healthy circuit functioning ([@bib2]; [@bib9]; [@bib63]; [@bib65]). Moreover, Ab increased pyramidal neuron excitability and caused a major reduction in excitatory synaptic transmission in the hippocampus, similar to what is reported in AD mouse models ([@bib23]; [@bib41]; [@bib60]). Thus, soluble Ab, at low concentrations, causes the dysfunction of vulnerable PV neurons and of associated vulnerable hippocampal circuitry.

Amyloid Load and PV Cell Hyperexcitability as Dual Risk Factors in AD {#sec3.4}
---------------------------------------------------------------------

Since the introduction of the amyloid cascade hypothesis, it is becoming increasingly clear that risk factors other than Ab need to be considered to explain the complex etiology of AD (e.g., [@bib22]). From previous studies it is known that Ab can cause PV neuron hyperexcitability ([@bib23]) but also that PV neurons contribute significantly to Ab production and Ab load ([@bib29]; [@bib51]). This suggests a model in which increasing Ab concentrations increase PV neuron excitability, whereas hyperexcitable PV neurons in turn increase Ab release and Ab load. Both Ab load and PV hyperexcitability can thus be considered risk factors in AD, and together they can trigger a detrimental cycle of pathological protein aggregation, neuronal circuit dysfunction, and cognitive decline. It has also been shown, however, that Ab can induce pyramidal neuron hyperexcitability ([@bib6]; [@bib69]) and that other interneurons also become dysfunctional in AD ([@bib57]). The question thus remains whether Ab toxicity shows any bias toward specific neuronal types and whether the data we obtained are the result of direct or indirect effects of Ab on PV neurons. Interestingly, previous studies have proposed that PV neurons are resistant to neurodegeneration, as the number of PV neurons was found unchanged in postmortem brain tissue of AD patients ([@bib17]; [@bib25]; [@bib39]). Although other studies have challenged these findings ([@bib5]; [@bib55]; [@bib56]; [@bib62]; [@bib64]), our data do not necessarily contradict either of these views and merely show that PV neurons become functionally impaired in early AD stages ([@bib23]), irrespective of how their viability changes on the long term. More research investigating different types of neurons and their specific vulnerability to Ab toxicity during disease progression is needed to better understand the complexity of circuit dysfunction in AD. However, given the fact that PV interneurons seem to be affected in multiple brain disorders, they remain an attractive target for identifying novel disease mechanisms and interventions.

Limitations of the Study {#sec3.5}
------------------------

To test whether hyperexcitable PV interneurons are a predisposing risk factor for AD, we created a model where PV cells were made hyperexcitable in the absence of Ab and then tested the impact of Ab injection on the hippocampal network. It is important to note that Ab injections are artificial and do not mimic AD pathology *in vivo*. Ideally, these experiments would be repeated in a mouse model of AD where PV neuron hyperexcitability can be induced before Ab levels start to increase. However, at this moment the artificial separation in time of PV neuron hyperexcitability and the presence of Ab allowed us to clearly demonstrate that hippocampal network vulnerability alone can increase risk for Ab toxicity. Also, although our study centered on the effects of Ab, AD is also characterized by the accumulation of hyperphosphorylated Tau protein. In a recent study, it was shown that Tau suppresses neuronal activity and that this tau-mediated suppression dominates over Ab-induced hyperactivity ([@bib8]). The combined and time-dependent effects of Ab and Tau in relation to PV neuron excitability clearly need further investigation in the future. Finally, although our study focused on CA1 networks, the effects of changes in PV neuron excitability in the rest of the hippocampus remain unknown. Various studies have highlighted the importance of CA2 and CA3 PV neuron plasticity in learning and memory ([@bib12]; [@bib13]; [@bib40]), and these specific networks are also impaired in AD ([@bib4]; [@bib45]; [@bib61]; [@bib67]). It would therefore be interesting for future studies to explore how alterations in PV neuron activity in different subregions of the hippocampus affect learning and memory and how these circuits are altered in response to hyperexcitable PV neurons. Despite these limitations, our study clearly demonstrates that PV neuron hyperexcitability increases the vulnerability of hippocampal circuitry to Ab-induced toxicity and impairs spatial memory accordingly.
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